Sponsors and Partners

As the only patient initiative dedicated to primary aldosteronism, the Foundation is uniquely positioned to provide access to a diverse and engaged constituent base. Our worldwide reach makes us an ideal vector to convene corporate and industry leaders with interest in improving health outcomes. While giving the Foundation greater financial flexibility to achieve its mission, corporate partners also engage with the organization at various levels to strengthen its programs and deepen its community outreach.


Headquartered in Philadelphia, PA, Mineralys Therapeutics LLC is a private, clinical-stage biopharmaceutical company committed to developing best-in-class, novel therapy for the treatment of hypertension. The company and the Primary Aldosteronism Foundation share the same vision of a paradigm-shifting approach to the unmet medical needs of millions of patients affected by elevated aldosterone. Recognizing this alignment, Mineralys Therapeutics LLC is awarding the Foundation seed money to enable its day-to-day operation while it takes necessary steps to ensure sustainability of its programs.

By matching community talents with community needs, Jericho Road Pasadena helps nonprofits become more efficient and effective, as well as enrich the lives of volunteers. Through the organization’s pro bono services, nonprofits can achieve more goals and expand the reach of their programs. Thanks to Jericho Road Pasadena, the Foundation is able to work with experienced prospect researchers and grant writers to identify new sources of funding and ways to leverage them.

Amazon Web Services provides a cloud-based infrastructure platform to hundreds of thousands of businesses in 190 countries around the world. With data center locations in the U.S., Europe, Brazil, Singapore, Japan, and Australia, Amazon Web Services supports the Foundation through its annual grants program for charities.


Other Foundations and Non-Profit Organizations

Since excess aldosterone is involved in various diseases, the Foundation prioritizes partnerships with organizations dedicated to advancing co-occurring disorders. Through this effort, shared values are used as a basis to building capacity and achieving common objectives.

Research and Academia

The Foundation partners with research and academic institutions worldwide to include patients’ lived experiences in the research process, promote clinical trials, disseminate findings, and leverage implementation science research. 

Health Care Organizations

To improve standards of care, the Foundation builds partnerships with public health and regulatory agencies, medical societies, payors, and health systems to implement the frameworks needed to provide diagnosis and treatment at scale. Knowledge translation and dissemination, and the development of geo-location tools and directories are some of the collaborative efforts deployed to this effect.

Business Development and Technology

Programs’ delivery depends on the Foundation’s ability to meet its operational and business needs in a sustainable way. Since most funders do not account for such necessities, the Foundation relies on partners to support the acquisition and management of business resources and methods such as IT infrastructure and services, talent and knowledge, public relations, and financial services.

Do you offer a product or service that can benefit patients with primary aldosteronism? Do you maintain physicians’ portals? Do you develop clinical research applications? Do you specialize in cause marketing? These are a few of the factors critical to the Foundation’s growth and where partnerships can have a meaningful impact. Let’s explore partnership opportunities and find ways to tailor your sponsorship to our programs! Please complete the form below, and we will contact you upon receipt of your information. Fields marked with a red asterisk are required.

Contact Person:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.